Tag:
Access Pharmaceuticals
Latest Headlines
Latest Headlines
Mystery RNAi player taps Access Pharma for oral delivery tech
Access Pharmaceuticals ( $ACCP ) has landed a deal to provide its drug-delivery technology to an unnamed "major" developer of RNA-interference drugs. The deal covers use of Access's...
Access Pharma tapping investors for $5.2M
Access Pharmaceuticals has accessed the investment community for a $5.2 million private placement, as the developer aims to beef up sales of one of its products that uses its hydrogel tech to prevent...
Access Pharmaceuticals rebrands, aims for siRNA
Dallas-based Access Pharmaceuticals is reporting that it has made progress with its Cobalamin-targeted drug-delivery program for siRNA therapies. Indeed, it has rebranded its targeted-drug delivery
Access Pharma uses Trojan Horse to sneak into oral insulin
Access Pharmaceuticals says it has entered into a prelicensing deal with "a major biotech partner," although the Dallas-based company won't say who its partner is nor will it reveal any financial
